Azzouni Dounia, Alaoui Mrani Soukaina, Bahij Fadoua, Zejli Hind, Alanazi Mohammed M, Fadili Driss, El Moussaoui Abdelfattah, Mahmoud Ayman M, Taleb Mustapha
Engineering, Electrochemistry, Modelling and Environment Laboratory, Faculty of Sciences, Sidi Mohamed Ben Abdellah University, Fez 30000, Morocco.
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Pharmaceuticals (Basel). 2025 Mar 25;18(4):462. doi: 10.3390/ph18040462.
The phytochemical composition, antioxidant, and antibacterial properties of L. essential oil (VACEO), extracted from fruit harvested in the Middle Atlas region of Morocco, were investigated. A full chemical analysis of VACEO was performed to identify the principal components of the oil using GC-MS, demonstrating that caryophyllene (13.87%), 1-(4-Isopropylphenyl)-2-methylpropyl acetate (12.20%), and τ-Cadinol (5.41%) were the most important constituents of this oil. In addition, antioxidant activity was evaluated using DPPH, FRAP, TAC, and beta-carotene bleach tests; the oil demonstrated an IC50 of 0.93 ± 0.03 mg/mL (DPPH), an EC50 of 0.146 ± 0.004 mg/mL (FRAP), and a total antioxidant capacity of 0.794 ± 0.02 mg BHT equivalent/g EO, with relative antioxidant activity at 72.69 ± 0.3%. Antibacterial assays revealed inhibition diameters ranging from 13.25 ± 1.00 mm to 21.11 ± 0.25 mm, with minimum inhibitory concentrations (MICs) ranging from 0.02-0.04 mg/mL against , , , and . Moreover, ADMET analysis suggested VACEO potential for drug development, with specific insights into pharmacokinetics, safety, and molecular docking, clarifying its interactions with key bacterial proteins. These results confirm the promising therapeutic and pharmaceutical potential of VACEO through its bioactive compounds.
对从摩洛哥中阿特拉斯地区收获的果实中提取的薰衣草精油(VACEO)的植物化学成分、抗氧化和抗菌特性进行了研究。使用气相色谱 - 质谱联用仪(GC - MS)对VACEO进行了全面的化学分析,以确定该精油的主要成分,结果表明石竹烯(13.87%)、1 - (4 - 异丙基苯基) - 2 - 甲基丙基乙酸酯(12.20%)和τ - 杜松醇(5.41%)是该精油的最重要成分。此外,使用DPPH、FRAP、TAC和β - 胡萝卜素漂白试验评估了抗氧化活性;该精油在DPPH试验中的IC50为0.93±0.03 mg/mL,在FRAP试验中的EC50为0.146±0.004 mg/mL,总抗氧化能力为0.794±0.02 mg BHT当量/g EO,相对抗氧化活性为72.69±0.3%。抗菌试验显示抑菌直径范围为13.25±1.00 mm至21.11±0.25 mm,对金黄色葡萄球菌、大肠杆菌、枯草芽孢杆菌和白色念珠菌的最低抑菌浓度(MICs)范围为0.02 - 0.04 mg/mL。此外,ADMET分析表明VACEO具有药物开发潜力,并对药代动力学、安全性和分子对接有具体见解,阐明了其与关键细菌蛋白的相互作用。这些结果通过其生物活性化合物证实了VACEO具有广阔的治疗和制药潜力。